What does APOTHEEK WOLFSDONK do?

APOTHEEK WOLFSDONK is a pharmacy in Aarschot. Private Limited, started on 13 March 1986, 1 establishment.

What is the address of APOTHEEK WOLFSDONK?

The registered office of APOTHEEK WOLFSDONK is located at Boeckxplein 1, 3201 Aarschot.

Is APOTHEEK WOLFSDONK still active?

Yes. According to the CBE (30 October 2026) APOTHEEK WOLFSDONK is active, legal situation “Normale toestand”, started on 13 March 1986.

Is APOTHEEK WOLFSDONK registered on Peppol?

Yes, APOTHEEK WOLFSDONK is registered on the Peppol network with ID 0208:0428585491.

What is the enterprise number of APOTHEEK WOLFSDONK?

The enterprise number of APOTHEEK WOLFSDONK is BE0428585491.

When was APOTHEEK WOLFSDONK founded?

APOTHEEK WOLFSDONK was founded on 13 March 1986.

Who are the directors of APOTHEEK WOLFSDONK?

According to the 2025 annual accounts, the directors of APOTHEEK WOLFSDONK are: M.C. Beurms BV.

Is APOTHEEK WOLFSDONK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 March 1986; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK WOLFSDONK make in 2025?

APOTHEEK WOLFSDONK posted a profit after taxes of € 248,761 in financial year 2025.

What is the revenue of APOTHEEK WOLFSDONK?

As a small company, APOTHEEK WOLFSDONK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 450,222.

How much does an employee at APOTHEEK WOLFSDONK earn?

The average wage cost per full-time employee at APOTHEEK WOLFSDONK was € 63,900 in 2025: staff costs of € 127,776 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK WOLFSDONK have?

According to the 2025 annual accounts, APOTHEEK WOLFSDONK has 2 full-time equivalents (FTE).

APOTHEEK WOLFSDONK (Private Limited) - Aarschot

Dossier APOTHEEK WOLFSDONK, printed on 30 October 2026 from databakkes.be/en/0428585491/apotheek-wolfsdonk. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK WOLFSDONK from Aarschot, company number BE0428585491, closed financial year 2025 with a result of € 248,761 after tax. For that financial year APOTHEEK WOLFSDONK recorded a gross margin of € 450,222 and equity of € 423,599. Compared with financial year 2024, the result moved from € 228,415 to € 248,761. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Growing

€ 423,599

▲ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 248,761

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 766,133

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

20 % of the profit went to the shareholders, mostly to M.C. BEURMS (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 127,776

▼ 4% vs 2024

€ 63,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,588

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 83,580

▲ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,443

▲ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 365,806 Gross margin 2022: € 365,806 First fiscal year in the series	€ 389,119 Gross margin 2023: € 389,119 ▲ 6% vs 2022 (€ 365,806) Favourable step	€ 432,197 Gross margin 2024: € 432,197 ▲ 11% vs 2023 (€ 389,119) Favourable step	€ 450,222 Gross margin 2025: € 450,222 ▲ 4% vs 2024 (€ 432,197) Favourable step	▲ 4%
Profit after taxes	€ 227,229 Profit after taxes 2022: € 227,229 First fiscal year in the series	€ 236,369 Profit after taxes 2023: € 236,369 ▲ 4% vs 2022 (€ 227,229) Favourable step	€ 228,415 Profit after taxes 2024: € 228,415 ▼ 3% vs 2023 (€ 236,369) Unfavourable step	€ 248,761 Profit after taxes 2025: € 248,761 ▲ 9% vs 2024 (€ 228,415) Favourable step	▲ 9%
Equity	€ 46,054 Equity 2022: € 46,054 First fiscal year in the series	€ 46,423 Equity 2023: € 46,423 ▲ 1% vs 2022 (€ 46,054) Favourable step	€ 224,838 Equity 2024: € 224,838 ▲ € 178,415 vs 2023 (€ 46,423) Favourable step	€ 423,599 Equity 2025: € 423,599 ▲ 88% vs 2024 (€ 224,838) Favourable step	▲ 88%
Total debts	€ 604,529 Total debts 2022: € 604,529 First fiscal year in the series	€ 815,436 Total debts 2023: € 815,436 ▲ 35% vs 2022 (€ 604,529) Unfavourable step	€ 888,787 Total debts 2024: € 888,787 ▲ 9% vs 2023 (€ 815,436) Unfavourable step	€ 922,295 Total debts 2025: € 922,295 ▲ 4% vs 2024 (€ 888,787) Unfavourable step	▲ 4%
Cash	€ 354,655 Cash 2022: € 354,655 First fiscal year in the series	€ 435,465 Cash 2023: € 435,465 ▲ 23% vs 2022 (€ 354,655) Favourable step	€ 550,960 Cash 2024: € 550,960 ▲ 27% vs 2023 (€ 435,465) Favourable step	€ 766,133 Cash 2025: € 766,133 ▲ 39% vs 2024 (€ 550,960) Favourable step	▲ 39%
Land & buildings	€ 449 Land & buildings 2022: € 449 First fiscal year in the series	€ 336 Land & buildings 2023: € 336 ▼ 25% vs 2022 (€ 449) Unchanged	€ 224 Land & buildings 2024: € 224 ▼ 33% vs 2023 (€ 336) Unchanged	€ 9,371 Land & buildings 2025: € 9,371 ▲ € 9,147 vs 2024 (€ 224) Unchanged	▲ € 9,147
Retained profit	€ 26,054 Retained profit 2022: € 26,054 First fiscal year in the series	€ 26,423 Retained profit 2023: € 26,423 ▲ 1% vs 2022 (€ 26,054) Favourable step	€ 204,838 Retained profit 2024: € 204,838 ▲ € 178,415 vs 2023 (€ 26,423) Favourable step	€ 403,599 Retained profit 2025: € 403,599 ▲ 97% vs 2024 (€ 204,838) Favourable step	▲ 97%
Dividend	€ 225,000 Dividend 2022: € 225,000 First fiscal year in the series	€ 236,000 Dividend 2023: € 236,000 ▲ 5% vs 2022 (€ 225,000) Unchanged	€ 50,000 Dividend 2024: € 50,000 ▼ 79% vs 2023 (€ 236,000) Unchanged	€ 50,000 Dividend 2025: € 50,000 Unchanged (€ 50,000) Unchanged
Balance sheet total	€ 650,583 Balance sheet total 2022: € 650,583 First fiscal year in the series	€ 861,859 Balance sheet total 2023: € 861,859 ▲ 32% vs 2022 (€ 650,583) Unchanged	€ 1,113,625 Balance sheet total 2024: € 1,113,625 ▲ 29% vs 2023 (€ 861,859) Unchanged	€ 1,345,894 Balance sheet total 2025: € 1,345,894 ▲ 21% vs 2024 (€ 1,113,625) Unchanged	▲ 21%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2 Employees (FTE) 2023: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of APOTHEEK WOLFSDONK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK WOLFSDONK?

What happened at APOTHEEK WOLFSDONK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 248,761 (▲ 9% vs 2024). Source: NBB ↗
Mar 13, 1986 Start of the company according to the CBE. KBO
Jan 1, 1986 New establishment in Aarschot. KBO

In short

From € 227,229 profit in 2022 to € 248,761 profit in 2025.

Paid € 127,444 in corporate taxes since 2022.

Best year ever: 2025, with € 248,761 profit.

On average € 225,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

M.C. BEURMS 100%

The stake of M.C. BEURMS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK WOLFSDONK

Behind APOTHEEK WOLFSDONK is M.C. Beurms BV. The shares are held by M.C. BEURMS (100%).

Directors

According to the 2025 annual accounts

M.C. Beurms BV

Director · represented by Beurms Chris

Shareholders

M.C. BEURMS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Boeckxplein 1

3201 Aarschot

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

M.C. BEURMS same network

€ 203,812 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0428.585.491

VAT number

BE 0428.585.491

Registered office

Boeckxplein 1, 3201 Aarschot

Names & denominations

APOTHEEK WOLFSDONK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 March 1986

Peppol

Active · Active since 14 Jan 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK WOLFSDONK

Financials

What happened to APOTHEEK WOLFSDONK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions